Live Breaking News & Updates on Covid 19 vaccine rollout

Stay informed with the latest breaking news from Covid 19 vaccine rollout on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covid 19 vaccine rollout and stay connected to the pulse of your community

Novavax Covid vaccine can still catch up to Pfizer, Moderna shots

Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay.

United-states , Americans , Mayank-mamtani , Silvia-taylor , Drug-administration , Pfizer , Walgreens , Centers-for-disease , Wall-street , Roger-song , Disease-control , Business

FDA authorizes Novavax updated Covid vaccine

Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.

United-states , Americans , Megan-wallace , John-jacobs , Drug-administration-on , Centers-for-disease , Access-program , Pfizer , Drug-administration , Disease-control , Demetre-daskalakis , Bridge-access-program

Covid vaccine rollout: Some patients see insurance coverage delays

The reports are fueling confusion among insured patients about whether they can still access Covid shots for free — just as cases tick up across the country.

Florida , United-states , Americans , Sarah-lindsey , Centers-for-medicare-medicaid-services , Twitter , Pfizer , Medicaid-services , Florida-blue , Blue-cross-shield , Covid-19-pandemic , Covid-19

New Covid vaccines: CDC advisors recommend Pfizer and Moderna shots

CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.

United-states , Americans , Beth-bell , Georgina-peacock , Megan-wallace , Mandy-cohen , Drug-administration , Pfizer , Centers-for-disease , University-of-washington , Disease-control , Breaking-news-business

Covid vaccines: FDA approves new shots from Pfizer, Moderna

The Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.

United-states , Americans , Albert-bourla , Pfizer , Drug-administration-on , Centers-for-disease , Drug-administration , Disease-control , Fda , Centers-for-disease-control-and-prevention , Immunizations , Covid-19-vaccine-rollout

Moderna says new Covid vaccine effective against BA.2.86 variant

Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.

Stephen-hoge , Drug-administration , Centers-for-disease , Pfizer , Disease-control , Moderna-president-stephen-hoge , Vaccinations , Coronavirus , Covid-19 , Breaking-news , Novavax-inc , Pfizer-inc

Covid: When to wear masks as cases rise, new variants emerge in U.S.

The decision to mask depends on a few things: your personal risk level, Covid rates in your region and who you might make contact with, experts say.

California , United-states , San-diego , Americans , Pavitra-roychoudhury , Andrew-pekosz , Francesca-torriani , University-of-california , Johns-hopkins-bloomberg-school-of-public-health , Pfizer , University-of-washington-school-medicine , Centers-for-disease

Covid vaccine stocks jump as new variants emerge

Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.

Denmark , Israel , Us-health , Pfizer , Us-centers-for-disease , World-health-organization , Wall-street , Disease-control , Business , Biotechnology , Biotech-and-pharmaceuticals

Covid: New vaccines will likely protect against Eris variant

The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.

Pfizer , Drug-administration , Coronavirus , Immunizations , Covid-19-vaccine-rollout , Vaccinations , Covid-19 , Breaking-news , Science , Novavax-inc , Moderna-inc

Covid vaccine: What uptake of new shots could look like

Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.

United-states , Americans , Pfizer , Business , Biotechnology , Biotech-and-pharmaceuticals , Pharmaceuticals , Health-care-industry , Social-issues , Science , Pfizer-inc